Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment.
In addition, the IGT market is influenced by technological innovations in MRI, CT, molecular imaging, ultrasound, and interventional X-ray during oncology, cardiology, neurosurgery, orthopedic, and urology procedures. The integration of the aforementioned medical imaging modalities with navigation systems and robotics has enabled higher precision and accuracy during surgical procedures.
IGT is expected to sustain steady growth during the next 5 years, fueled by increasing expenditures and investments in research and development that drive market expansion. Minimally invasive procedures are also expected to see higher adoption than conventional surgical procedures, which will propel IGT market growth.
The study period is from 2022 to 2029, the base year is 2024, and the forecast period is from 2025 to 2029. The study analyzes the North American, European, Asia-Pacific, and Rest of World markets, focusing on current scenarios, drivers and restraints, the latest technologies, and notable participants.
The report segments the IGT market into the following categories:
- Product type:
- Capital equipment
- Medical devices and consumables
- Solutions
- Clinical applications: oncology, cardiology, neurosurgery, urology, and orthopedics
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Elekta
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- GE HealthCare
- Ziehm Imaging
